The higher risk of developing cardiovascular pathologies in the elderly with high serum levels of Fetuin-A is in fact associated with a much higher risk of developing obesity, T2DM and dyslipidemias (because fetuin A has the ability to reduce lipogenesis and to accentuate the lipolysis process) [65]. The gene discussed is AHSG; the disease is metabolic syndrome.